Lurasidone Effects on Tissue Glutamate in Schizophrenia
Phase of Trial: Phase IV
Latest Information Update: 02 Jan 2017
At a glance
- Drugs Lurasidone (Primary) ; Haloperidol; Perphenazine
- Indications Schizophrenia
- Focus Therapeutic Use
- 28 Dec 2016 Status changed from active, no longer recruiting to completed.
- 13 May 2016 Status changed from recruiting to active, no longer recruiting.
- 29 May 2015 Planned End Date changed from 1 Dec 2014 to 1 Jun 2016 as reported by ClinicalTrials.gov record.